EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing molecular diagnostics of myotonic dystrophy type 1 using short-read whole genome sequencing

Ingrid Lojova, Marcel Kucharik, Zuzana Pös, Andrej Balaz, Andrea Zatkova, Eva Tothova Tarova, Jaroslav Budis, Ludevit Kadasi, Tomas Szemes, Jan Radvanszky

Molecular and Cellular Probes · 2025

DOI: 10.1016/j.mcp.2024.102005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Probes, 2025. Verfasst von Ingrid Lojova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia; Comenius Univer…. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Whole Genome Sequencing, Molecular Diagnostic Techniques. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myotonic dystrophy type 1 (DM1) is a serious multisystem disorder caused by GCA repeat expansions in the DMPK gene. Early and accurate diagnosis, often requiring reliable DNA-diagnostic techniques, is critical for preventing life-threatening cardiac complications. Clinically, two main diagnostic challenges exist. Firstly, because of overlapping symptomatology with other conditions, conventional DNA-testing methods focusing on DM1 expansion detection ensure diagnostic results only in a small subset of patients, and frequently, further DNA-testing in remaining cases is necessary. Secondly, because of variable symptomatology and age of onset, not all DM1 patients are referred for DM1 genetic testing, leading to unrecognized but at-risk cases. When using conventional methods, the main technical problems are expanded-allele sizing and sensitivity to the presence of sequence interruptions. On a set of 50 individual genomes, including ten DM1 patients, we tested the performance of short-read whole-genome sequencing (WGS), one of the most up-to-date molecular testing methods. We identified all expansion-range DM1 alleles and characterized sequence interruptions in seven expansion-range/premutation-range alleles. Although neither the tested conventional methods, nor WGS allowed expanded-allele sizing, conventional methods provided higher sizing limits for normal-range alleles. Genotyping concordance rate was found to be 95-99 %. WGS was found to be superior in elucidating the sequence structure of the motifs, even if they fall outside the sizing limit (from partial reads). In addition, WGS enables the identification of genetic modifiers in other genes and the detection of alternative diagnoses in DM1-negative patients by extension of the bioinformatic evaluation of the generated data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyWhole Genome SequencingMolecular Diagnostic TechniquesHumansAllelesMaleFemaleMyotonin-Protein KinaseAdultMiddle Aged

Stichwörter der Autor:innen

Massively parallel sequencingMyotonic dystrophy type 1Repeat expansion disordersTandem repeatsWhole genome sequencing

Substanzen

Myotonin-Protein KinaseDMPK protein, human

Autor:innen und Institutionen

  • Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia; Comenius University Science Park, Bratislava, Slovakia; Department of Molecular Biolo…
  • Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia; Comenius University Science Park, Bratislava, Slovakia; Geneton Ltd., Bratislava, Slo…
  • Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia; Geneton Ltd., Bratislava, Slovakia.
  • Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia; Geneton Ltd., Bratislava, Slovakia; Faculty of Mathematics, Physics and Informatics,…
  • Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia.
  • Institute of Clinical and Translational Research, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia; Department of Biology, Faculty of Education, J. Selye University, Komárno, Slovakia.

Zitieren

APA

Lojova, I., Kucharik, M., Pös, Z., Balaz, A., Zatkova, A., Tothova Tarova, E., Budis, J., Kadasi, L., Szemes, T., & Radvanszky, J. (2025). Advancing molecular diagnostics of myotonic dystrophy type 1 using short-read whole genome sequencing. Molecular and Cellular Probes. https://doi.org/10.1016/j.mcp.2024.102005

Vancouver

Lojova I, Kucharik M, Pös Z, Balaz A, Zatkova A, Tothova Tarova E, et al. Advancing molecular diagnostics of myotonic dystrophy type 1 using short-read whole genome sequencing. Molecular and Cellular Probes. 2025. doi:10.1016/j.mcp.2024.102005

BibTeX
@article{Lojova2025,
  author = {Lojova, Ingrid and Kucharik, Marcel and Pös, Zuzana and Balaz, Andrej and Zatkova, Andrea and Tothova Tarova, Eva and Budis, Jaroslav and Kadasi, Ludevit and Szemes, Tomas and Radvanszky, Jan},
  title = {Advancing molecular diagnostics of myotonic dystrophy type 1 using short-read whole genome sequencing},
  journal = {Molecular and Cellular Probes},
  year = {2025},
  doi = {10.1016/j.mcp.2024.102005}
}
Kostenlos starten →